WASHINGTON - The U.S. Food and Drug Administration cited multiple inspection failures at a Baltimore plant that is a proposed manufacturing facility for the Johnson & Johnson COVID-19 vaccine, according to a report issued Wednesday.During the inspection, the FDA cited a number of observations at Emergent BioSolutions concerning whether the facility’s processes met the administration’s requirements and standards.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.